Perfil
Francesco Mazzotta is the founder of Pilloxa AB, a company he founded in 2015.
He currently holds the title of Chief Commercial Officer at Pilloxa AB.
Cargos activos de Francesco Mazzotta
| Empresas | Cargo | Inicio |
|---|---|---|
Pilloxa AB
 Pilloxa AB Internet Software/ServicesTechnology Services Part of iZafe Group AB, Pilloxa AB is a Swedish company that develops apps for patients to support them in adhering to their treatment and to connect patients, healthcare providers, and the pharmaceutical industry. The company is based in Stockholm, Sweden. Pilloxa was acquired by iZafe Group AB on November 28, 2022 for $1.32 million. The company provides a SaaS platform where pharmaceutical companies and other customers can design digital patient support quickly, securely, and at a low cost. Pilloxa's self-developed smart medication dose can also be connected to the service to support patients in taking the correct medication. The company was founded in 2015 by Helena Rönnqvist, Francesco Mazzotta, Per Åke Filip Nilsson. Helena Rönnqvist has been the CEO since 2015. | Fundador | 01/01/2015 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Pilloxa AB
Pilloxa AB Internet Software/ServicesTechnology Services Part of iZafe Group AB, Pilloxa AB is a Swedish company that develops apps for patients to support them in adhering to their treatment and to connect patients, healthcare providers, and the pharmaceutical industry. The company is based in Stockholm, Sweden. Pilloxa was acquired by iZafe Group AB on November 28, 2022 for $1.32 million. The company provides a SaaS platform where pharmaceutical companies and other customers can design digital patient support quickly, securely, and at a low cost. Pilloxa's self-developed smart medication dose can also be connected to the service to support patients in taking the correct medication. The company was founded in 2015 by Helena Rönnqvist, Francesco Mazzotta, Per Åke Filip Nilsson. Helena Rönnqvist has been the CEO since 2015. | Technology Services |
- Bolsa de valores
- Insiders
- Francesco Mazzotta
